Trump’s Pick for HHS Tells Senate Drug Prices are Too High

International Pharmaceutical Regulatory Monitor
A A
President Trump’s nominee for the next secretary of HHS, former Eli Lilly executive Alex Azar, told the Senate’s health committee he agrees prescription drug prices are too high, and would welcome congressional action if appointed to the post.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor